Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Jul 1;357(Pt 1):147–155. doi: 10.1042/0264-6021:3570147

Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.

H Unwalla 1, A C Banerjea 1
PMCID: PMC1221937  PMID: 11415445

Abstract

Many regions of the HIV-1 genome have been targeted in earlier studies by RNA-cleaving DNA enzymes possessing the 10-23 catalytic motif, and efficient inhibition of HIV-1 gene expression was reported. All these studies employed charged synthetic lipids to introduce the catalytic DNA into the mammalian cells, which severely limits its practical application and usefulness in vivo. Taking advantage of the ability of G residues to interact directly with the scavenger receptors on the macrophages, we synthesized a DNA enzyme 5970 that contained 10 G residues at the 3' end. With the aim of improving the intracellular stability of the DNA enzyme 5970, we added two short stretches of stem-loop structures that were 12 bases long on either side of the DNA enzyme 5970. DNA enzyme 5970 without the poly-G tracts cleaved the synthetic RNA of HIV-1 TAT/Rev, two important regulatory proteins of HIV, very efficiently in a sequence-specific manner. Addition of 10 G residues at the 3' end of the DNA enzyme affected the cleavage efficiency only marginally whereas the same DNA enzyme with stem-loop structures on either end was significantly less efficient. The DNA enzyme with the poly-G tract at its 3' end was taken up specifically by a human macrophage-specific cell line directly in the absence of Lipofectin and was also able to inhibit HIV-1 gene expression in a transient-expression system as well as when challenged with the virus. The potential applications of these novel macrophage-tropic DNA enzymes are discussed.

Full Text

The Full Text of this article is available as a PDF (259.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986 Aug;59(2):284–291. doi: 10.1128/jvi.59.2.284-291.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Banerjea A. C., Joklik W. K. Reovirus protein sigma 1 translated in vitro, as well as truncated derivatives of it that lack up to two-thirds of its C-terminal portion, exists as two major tetrameric molecular species that differ in electrophoretic mobility. Virology. 1990 Nov;179(1):460–462. doi: 10.1016/0042-6822(90)90315-i. [DOI] [PubMed] [Google Scholar]
  3. Basu S., Sriram B., Goila R., Banerjea A. C. Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: inhibition of coreceptor function. Antiviral Res. 2000 May;46(2):125–134. doi: 10.1016/s0166-3542(00)00075-9. [DOI] [PubMed] [Google Scholar]
  4. Berger E. A., Murphy P. M., Farber J. M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. doi: 10.1146/annurev.immunol.17.1.657. [DOI] [PubMed] [Google Scholar]
  5. Dash B. C., Harikrishnan T. A., Goila R., Shahi S., Unwalla H., Husain S., Banerjea A. C. Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. FEBS Lett. 1998 Jul 24;431(3):395–399. doi: 10.1016/s0014-5793(98)00799-6. [DOI] [PubMed] [Google Scholar]
  6. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27;273(5283):1856–1862. doi: 10.1126/science.273.5283.1856. [DOI] [PubMed] [Google Scholar]
  7. Fitzgerald M. L., Moore K. J., Freeman M. W., Reed G. L. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J Immunol. 2000 Mar 1;164(5):2692–2700. doi: 10.4049/jimmunol.164.5.2692. [DOI] [PubMed] [Google Scholar]
  8. Goila R., Banerjea A. C. Inhibition of hepatitis B virus X gene expression by novel DNA enzymes. Biochem J. 2001 Feb 1;353(Pt 3):701–708. doi: 10.1042/0264-6021:3530701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goila R., Banerjea A. C. Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme. FEBS Lett. 1998 Oct 2;436(2):233–238. doi: 10.1016/s0014-5793(98)01137-5. [DOI] [PubMed] [Google Scholar]
  10. Huang Y., Paxton W. A., Wolinsky S. M., Neumann A. U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996 Nov;2(11):1240–1243. doi: 10.1038/nm1196-1240. [DOI] [PubMed] [Google Scholar]
  11. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol. 1992 Apr;66(4):2232–2239. doi: 10.1128/jvi.66.4.2232-2239.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kuwabara T., Amontov S. V., Warashina M., Ohkawa J., Taira K. Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes. Nucleic Acids Res. 1996 Jun 15;24(12):2302–2310. doi: 10.1093/nar/24.12.2302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996 Aug 9;86(3):367–377. doi: 10.1016/s0092-8674(00)80110-5. [DOI] [PubMed] [Google Scholar]
  14. Paik S. Y., Banerjea A., Chen C. J., Ye Z., Harmison G. G., Schubert M. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis. Hum Gene Ther. 1997 Jun 10;8(9):1115–1124. doi: 10.1089/hum.1997.8.9-1115. [DOI] [PubMed] [Google Scholar]
  15. Pearson A. M., Rich A., Krieger M. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J Biol Chem. 1993 Feb 15;268(5):3546–3554. [PubMed] [Google Scholar]
  16. Prasad V., Hashim S., Mukhopadhyay A., Basu S. K., Roy R. P. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide. Antimicrob Agents Chemother. 1999 Nov;43(11):2689–2696. doi: 10.1128/aac.43.11.2689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rando R. F., Ojwang J., Elbaggari A., Reyes G. R., Tinder R., McGrath M. S., Hogan M. E. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J Biol Chem. 1995 Jan 27;270(4):1754–1760. doi: 10.1074/jbc.270.4.1754. [DOI] [PubMed] [Google Scholar]
  18. Santiago F. S., Lowe H. C., Kavurma M. M., Chesterman C. N., Baker A., Atkins D. G., Khachigian L. M. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med. 1999 Nov;5(11):1264–1269. doi: 10.1038/15215. [DOI] [PubMed] [Google Scholar]
  19. Santoro S. W., Joyce G. F. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4262–4266. doi: 10.1073/pnas.94.9.4262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sriram B., Banerjea A. C. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression. Biochem J. 2000 Dec 15;352(Pt 3):667–673. [PMC free article] [PubMed] [Google Scholar]
  21. Toyoda T., Imamura Y., Takaku H., Kashiwagi T., Hara K., Iwahashi J., Ohtsu Y., Tsumura N., Kato H., Hamada N. Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme. FEBS Lett. 2000 Sep 15;481(2):113–116. doi: 10.1016/s0014-5793(00)01974-8. [DOI] [PubMed] [Google Scholar]
  22. Wu Y., Yu L., McMahon R., Rossi J. J., Forman S. J., Snyder D. S. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum Gene Ther. 1999 Nov 20;10(17):2847–2857. doi: 10.1089/10430349950016573. [DOI] [PubMed] [Google Scholar]
  23. Zhang X., Xu Y., Ling H., Hattori T. Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme. FEBS Lett. 1999 Sep 17;458(2):151–156. doi: 10.1016/s0014-5793(99)01149-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES